Buprenorphine hydrochloride
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
778 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 60 | 131 | 67 | 69 | 202 | 502 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 16 | 22 | 11 | 14 | 58 | 116 |
| Chronic pain | D059350 | — | — | 8 | 10 | 7 | 9 | 17 | 47 |
| Pain | D010146 | EFO_0003843 | R52 | 8 | 4 | 10 | 11 | 11 | 43 |
| Heroin dependence | D006556 | EFO_0004240 | — | 4 | 15 | 10 | 4 | 5 | 34 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | 6 | 3 | 7 | 14 | 30 |
| Addictive behavior | D016739 | EFO_0004347 | — | 6 | 5 | 1 | 4 | 12 | 24 |
| Depression | D003863 | — | F33.9 | 4 | 5 | 7 | 2 | 9 | 24 |
| Healthy volunteers/patients | — | — | — | 16 | — | — | 2 | 6 | 24 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | — | 13 | 7 | 2 | 23 |
Show 60 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neonatal abstinence syndrome | D009357 | EFO_0005799 | P96.1 | 4 | 4 | 4 | — | 10 | 19 |
| Cocaine-related disorders | D019970 | — | F14 | 3 | 9 | 3 | — | 2 | 16 |
| Pregnancy rate | D018873 | — | — | 1 | — | 2 | — | 5 | 8 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | 1 | — | 5 | 7 |
| Narcotic-related disorders | D000079524 | — | — | — | 2 | 1 | — | 4 | 7 |
| Infections | D007239 | EFO_0000544 | — | 1 | 1 | 1 | — | 1 | 4 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | 1 | — | 2 | 3 |
| Smoking cessation | D016540 | EFO_0004319 | — | — | 1 | 1 | — | 2 | 3 |
| Neuralgia | D009437 | EFO_0009430 | — | — | — | 2 | — | 1 | 3 |
| Tobacco use disorder | D014029 | — | F17 | — | — | 1 | — | 2 | 3 |
Show 9 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | 3 | — | — | 6 | 9 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | 2 | — | — | 6 | 8 |
| Traumatic stress disorders | D040921 | — | — | — | 2 | — | — | 2 | 4 |
| Cigarette smoking | D000073865 | — | — | — | 1 | — | — | 2 | 3 |
| Mucositis | D052016 | EFO_1001898 | — | 1 | 2 | — | — | — | 2 |
| Recreational drug use | D000084783 | — | — | — | 1 | — | — | 1 | 2 |
| Craving | D066249 | — | — | — | 1 | — | — | 1 | 2 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | 1 | — | — | — | 2 |
| Dental pins | D003772 | — | — | — | 2 | — | — | — | 2 |
| Toothache | D014098 | — | K08.89 | — | 2 | — | — | — | 2 |
Show 21 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | — | — | — | 6 | 7 |
| Recurrence | D012008 | — | — | 2 | — | — | — | 2 | 4 |
| Pharmacokinetics | D010599 | — | — | 3 | — | — | — | — | 3 |
| Psychological well-being | D000092862 | — | — | 1 | — | — | — | 2 | 3 |
| Sleep wake disorders | D012893 | — | G47 | 1 | — | — | — | 2 | 3 |
| Respiratory insufficiency | D012131 | — | J96.9 | 1 | — | — | — | 1 | 2 |
| Tissue adhesions | D000267 | — | — | 2 | — | — | — | — | 2 |
| Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
| Musculoskeletal pain | D059352 | — | — | 1 | — | — | — | — | 1 |
| Hepacivirus | D016174 | — | — | 1 | — | — | — | — | 1 |
Show 7 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | — | — | 4 | 4 |
| Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 4 | 4 |
| Treatment adherence and compliance | D000074822 | — | — | — | — | — | — | 3 | 3 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 3 | 3 |
| Harm reduction | D040261 | — | — | — | — | — | — | 3 | 3 |
| Risk reduction behavior | D040242 | — | — | — | — | — | — | 2 | 2 |
| Patient acceptance of health care | D010342 | — | — | — | — | — | — | 2 | 2 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 2 | 2 |
| Immunologic deficiency syndromes | D007153 | — | D84.9 | — | — | — | — | 2 | 2 |
| Hyperalgesia | D006930 | — | — | — | — | — | — | 2 | 2 |
Show 36 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
12,085 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use